Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-02 @ 3:35 AM
Study NCT ID:
NCT06439056
Status:
COMPLETED
Last Update Posted:
2025-09-23
First Post:
2024-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Sponsor:
Nanexa AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2024-05-16
First Submit QC Date:
None
Study First Post Date:
2024-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-23
Last Update Post Date Type:
ESTIMATED